U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07179692) titled 'CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors' on Sept. 11.
Brief Summary: This study is a single-arm, open-label, dose-escalating + dose-expansion clinical study, aiming to evaluate the safety and efficacy of CEA-targeted CAR-T cell preparations, and to preliminarily observe the study drug in CEA-positive advanced malignant tumors. The pharmacokinetic characteristics of CAR-T cell preparations for the treatment of patients with CEA-positive advanced malignancies were obtained and the recommended dose and infusion schedule.
Study Start Date: Sept. 12
Study Type: INTERVENTIONAL
Condition:
Lung Cancer
Gastric C...